期刊文献+

P170蛋白的检测及其与结直肠癌术后化疗耐药的关系 被引量:1

Investigation on P170 protein expression in colorectal cancer and its relationship with postoperative chemotherapy resistance
原文传递
导出
摘要 目的观察结直肠癌患者手术后经4个化疗周期外周静脉血淋巴细胞P170蛋白的表达及其意义。方法用单克隆抗体免疫荧光法和流式细胞术检测患者外周静脉血淋巴细胞P170蛋白的表达,用统计学原理分析实验数据。结果在化疗药物诱导作用下,外周血P170蛋白的表达呈现上升态势,且差异明显(F=11.492,P<0.01);P170蛋白含量受化疗药物诱导的时间而升高。结论化疗药物可以诱导机体产生获得性多药耐药,并随药物诱导时间延续而越发显著。 Objective To observe patients with colorectal cancer that express P170 protein in peripheral blood lymphocytes after receiving four cycles of FOLFOX4 chemotherapy and to investigate the significance of such protein expression.Methods Immunofluorescence and flow-cytometry techniques were used to detect the expression of P170 protein in the peripheral blood and resulting experimental data was statistically analyzed.Results 1.Under the effects of chemotherapy,patients exhibited a trend of increased P170 protein expression showing a rising trend and the difference was significant(F = 11.492,P〈0.01).2.This trend of increased expression of P170 protein was more pronounced over time of chemotherapy exposure.Conclusion Chemotherapy can induce acquired multi-drug resistance,and this multi-drug resistance can become more pronounced over time.
出处 《公共卫生与预防医学》 2015年第2期24-26,共3页 Journal of Public Health and Preventive Medicine
基金 湖北省自然科学基金资助项目(2008CBD130)
关键词 结直肠癌 P170蛋白 多药耐药 FOLFOX4 Colorectal cancer P170 proteins Multi-drug resistance FOLFOX4
  • 相关文献

参考文献11

二级参考文献106

  • 1高鹏,周庚寅,张庆慧,周成军,甄军晖,孙妍琳.转染抗mdr-1核酶基因逆转肿瘤细胞耐药性的研究[J].中华病理学杂志,2004,33(3):251-254. 被引量:7
  • 2陈波,冯丽萍,林海平.联用奥沙利铂、5-氟脲嘧啶、亚叶酸钙治疗晚期胃癌的临床观察[J].武警医学院学报,2005,14(1):35-36. 被引量:4
  • 3张翠娟,周庚寅,李丽,喻芳,孙妍琳,马超.葡萄籽多酚对人乳腺癌细胞株MCF-7/ADR的体内外耐药逆转作用[J].山东大学学报(医学版),2004,42(6):640-642. 被引量:3
  • 4洪专,郑秀立.恶性肿瘤对抗癌药物的耐药问题[J].实用临床医药杂志,2005,9(11):2-7. 被引量:7
  • 5Weitz J, Koch M, Debus J, et al. Colorectal cancer [ J ]. Lancet,2005,365 : 153 - 165.
  • 6Beliberg H, De Gramont A. Oxaliplatin plus 5 - fluorouraci: 1 clinical experience in patients with advanced colorectal cancer[J] .J Semin Oncol, 1998,25(sup15) :32 - 39.
  • 7De Gramont A, Figer A. Leucovorin and fluorouracil with or without oxaliplatin as first- line treatment in advanced col- orectal cancer[J]. J Clin Oncol, 2000, 18 (12) : 2968 - 2947.
  • 8Krishna R, Mayer L D. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs [ J ]. Eur J Pharm Sci,2000,11 (4) :265 - 283.
  • 9Buda G, Orciuolo E, Maggini V,et al. MDR1 modulates apoptosis in CD34 + leukemic cells[ J]. Ann Hematol,2008,87 (12) : 1017 -1018.
  • 10Borst P, Evers R, Kool M, et al. A family of drug transporters : the muhidrug resistance-associated proteins [ J ]. J Natl Cancer Inst, 2000,92 ( 16 ) : 1295 - 1302.

共引文献44

同被引文献13

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部